- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-2-2-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose(Non-functional Binders)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.11: 5 residues within 4Å:- Chain D: N.203, T.205, P.207, S.243
- Chain F: K.54
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:K.54
NAG-NAG-BMA.22: 4 residues within 4Å:- Chain H: W.65, N.203, T.205, S.243
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.23: 5 residues within 4Å:- Chain H: E.180, P.181, N.231, C.346, V.413
1 PLIP interactions:1 interactions with chain H- Hydrogen bonds: H:V.413
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 41 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.27: 3 residues within 4Å:- Chain A: N.100, S.102, W.103
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.107
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain A: N.114
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain A: N.126, Y.127
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: E.56, N.57
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.105, N.106
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain B: N.117, L.136, D.289
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain B: S.119, F.120, N.121, K.132
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.245, T.247
Ligand excluded by PLIPNAG.36: 6 residues within 4Å:- Chain B: Q.262, I.263, N.264, N.300, V.301, S.302
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.307
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain B: R.318, N.323
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain B: N.360
Ligand excluded by PLIPNAG.40: 4 residues within 4Å:- Chain B: N.231, P.260, N.415
- Ligands: NAG-NAG.4
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.100, S.102
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: N.107, E.110
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.114
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain C: N.126, Y.127
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain D: E.56, N.57
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain D: N.102, K.116, Y.160
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain D: N.106
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain D: F.120, N.121, K.132
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain D: N.245, T.247
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain D: N.270, I.291
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain D: K.303, N.307, T.367
Ligand excluded by PLIPNAG.52: 3 residues within 4Å:- Chain D: P.260, N.415
- Ligands: NAG-NAG-BMA-MAN.12
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain D: G.426, T.428, N.429
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain G: N.100, S.102
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain G: N.107, E.110
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain G: N.126
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain G: G.13, G.16, S.17
- Chain H: E.56, N.57
Ligand excluded by PLIPNAG.58: 4 residues within 4Å:- Chain H: N.105, N.106, I.290, G.292
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain H: R.161, N.166, T.167
Ligand excluded by PLIPNAG.60: 2 residues within 4Å:- Chain H: N.245, T.247
Ligand excluded by PLIPNAG.61: 7 residues within 4Å:- Chain H: Q.262, N.264, N.300, V.301, S.302, S.380, R.411
Ligand excluded by PLIPNAG.62: 3 residues within 4Å:- Chain H: N.270, I.291, G.408
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain H: H.298, N.300, T.382
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain H: N.307, N.366, T.367
Ligand excluded by PLIPNAG.65: 1 residues within 4Å:- Chain H: N.360
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain H: S.365, N.366
- Chain J: Y.104
Ligand excluded by PLIPNAG.67: 4 residues within 4Å:- Chain H: G.426, S.427, T.428, N.429
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xu, Z. et al., Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer. Nat Commun (2022)
- Release Date
- 2022-06-22
- Peptides
- Transmembrane protein gp41: ACG
Envelope glycoprotein gp160: BDH
C05 Fab Light chain: EI
C05 Fab heavy chain: FJ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
DG
FB
CD
EH
GE
LI
IF
HJ
A
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-2-2-mer
- Ligands
- 21 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose(Non-functional Binders)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 41 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Xu, Z. et al., Induction of tier-2 neutralizing antibodies in mice with a DNA-encoded HIV envelope native like trimer. Nat Commun (2022)
- Release Date
- 2022-06-22
- Peptides
- Transmembrane protein gp41: ACG
Envelope glycoprotein gp160: BDH
C05 Fab Light chain: EI
C05 Fab heavy chain: FJ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BC
DG
FB
CD
EH
GE
LI
IF
HJ
A